The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian activity to the later stages of the manufacturing process, including dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.
As with those in the global pharmaceutical industry, domestic players are currently contending with the fallout of the patent cliff.
The industry comprises companies that manufacture various medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Manufacturing activities include the manufacture of active pharmaceutical ingredients and synthesis of chemical ingredients, through to late-stage packaging and fill-finish activities.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.